HomeAI · summaries
Storia in 5 fonti
Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The forever more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Pembrolizumab regimens snag FDA nod for muscle-invasive bladder cancer
The FDA has approved two immunotherapy combination therapies for adults with muscle-invasive bladder cancer. Pembrolizumab (Keytruda, Merck) or pembrolizumab and…
- ·
medpagetoday.com
FDA Expands Approval of Chemo-Free Bladder Cancer Combo in Curative Setting
Perioperative Keytruda-Padcev for MIBC approved regardless of cisplatin eligibility
